Allocetra from Israel’s Enlivex Therapeutics (reported here previously) has cured the majority of the 37 seriously and critically ill Covid-19 patients in its Phase 1b and 2 trials. 33 patients were discharged from hospital an average of under 6 days after treatment.

https://www.globenewswire.com/news-release/2021/02/03/2168999/0/en/Enlivex-Reports-Positive-Top-Line-Results-from-Phase-II-Clinical-Trial-Evaluating-Allocetra-in-Severe-and-Critical-COVID-19-Patients-and-Provides-a-Program-Update.html